Pfizer and Moderna could earn $32 billion in revenues from their COVID-19 vaccines in 2021 - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

Business Business Headlines News

Pfizer and Moderna could earn $32 billion in revenues from their COVID-19 vaccines in 2021

Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. alone, according to Wall Street estimates.

Pfizer and its German partner BioNTech are set to make roughly $19 billion, according to Morgan Stanley estimates, which project the companies could make almost $30 billion in vaccine revenues by the end of 2023. Pfizer expects to supply up to 1.3 billion doses of its shot in 2021, while Moderna expects to manufacture between 500 million and 1 billion doses.Visit Business Insider's homepage for more storiesUS drugmakers Pfizer and Moderna could rake in around $32 billion in revenues from their COVID-19 vaccines in 2021, according to Wall Street estimates.

Pfizer and its German partner BioNTech will bring in roughly $19 billion from global sales of its COVID-19 vaccine in 2021, according to Morgan Stanley estimates first reported by

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Those vaccines should be free!

They won’t

Check it out! Do You Want To create 3d logo animation intro video in $5? Please Contact Me : 3d Logo intro 3d Logo Animation Intro Video Video Intro

this is terrible news

How much will go as 'donation' & 'welfare' activities? COVID19 CovidVaccine Pfizervaccine Moderna Pfizer

What’s Fauci and gates’ cut?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSİNESS

Business Business Latest News, Business Business Headlines